January 17, 2013
The pharmaceutical company Boehringer Ingelheim recently launched the website www.HepCRedefined.com to provide resources and tools for individuals infected with the hepatitis C virus (HCV). The company collaborated with HCV community advocates and healthcare providers to create the portal, which offers a range of interactive tools and information that can be shared through social media channels, placed on other websites, or viewed on various smart devices. Michael Ninburg, executive director of the Hepatitis Education Project, states that "HepCRedefined.com is designed to aggregate straightforward and accurate information in a single, virtual destination." CDC estimates the United States recorded 16,000 cases of acute HCV and 3.2 million individuals with chronic HCV infection in 2009.
Gastroenterology & Endoscopy News
No comments have been made.
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.
|Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade|
|CROI 2018: Highlights and What's Next for Advocates|
|Reported PrEP 'Failure' Most Likely a Lack of Proper Testing and Adherence|
|Injection Drug Use Among People Living With HIV: A Missed Opportunity to Save Lives|
|Statin Use Might Reduce Risk of Cancer in HIV-Positive People|
|Insurers and Pharmas Must Help Fix HIV Drug Pricing System, Advocates Say|